Biomarkers of Sepsis Severity: A Comparative Evaluation of Immunological and Biochemical Parameters

Background: Sepsis is a significant health concern characterized by high mortality rates, further complicated by diagnostic challenges and the absence of reliable prognostic biomarkers. Objective: To investigate the clinical value of specific immunological parameters along with liver and kidney function tests in individuals with sepsis and their relationship to disease severity. Materials and Methods: In this research, we included 300 participants (100 healthy individuals as the control group and 200 patients in the sepsis group, including 100 with non-severe sepsis and 100 with severe sepsis). Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), C-X-C motif chemokine ligand 9 (CXCL9), C-C motif chemokine ligand 12 (CCL12), soluble urokinase plasminogen activator receptor (suPARIII), and monocyte chemoattractant protein-1 (MCP-1), creatinine (S-Cr), High-sensitive C-reactive protein (hs-CRP), platelet counts (PLT), and the PaO2/FiO2 ratio were measured for each participant. Results: Our results showed significantly increased (P-value < 0.05) levels of IL-6 and TNF-α in patients with non-severe sepsis and severe sepsis compared to the control group. The levels of CXCL9, CCL12, suPARIII, and MCP-1 were also significantly elevated in both non-severe sepsis and severe sepsis patients compared with the control group. Significantly higher levels of TSB, hs-CRP, and S-Cr were observed in the severe sepsis group compared to the control group. Conversely, platelet counts were markedly reduced in both non-severe and severe sepsis patients relative to controls. Conclusion: The study identified several critical immunological and biochemical markers that demonstrated a significant positive correlation with sepsis severity. Elevated levels of these immune response markers were consistently associated with more severe clinical presentations, underscoring their potential utility as early diagnostic and prognostic indicators in sepsis management.

Authors

Publication Details

Journal
Al- Anbar Medical Journal
Published
2025-09-29
DOI
https://doi.org/10.33091/amj.2025.159680.2222
Citations
1
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biomarkers of Sepsis Severity: A Comparative Evaluation of Immunological and Biochemical Parameters

Ali Saad Kadhim, Humera Ahmed, Giuseppe Lippi, Abdullah Salim Al-Karawi et al.
1 citations
Al- Anbar Medical Journal
Sepsis Diagnosis and Treatment
1.35
article

Biomarkers of Sepsis Severity: A Comparative Evaluation of Immunological and Biochemical Parameters

Ali Saad Kadhim, Humera Ahmed, Giuseppe Lippi, Abdullah Salim Al-Karawi, Rusul A.A. Alshammary, Maha M. Khadim, Ali R. Laftah
article en
1 citations

Abstract

Background: Sepsis is a significant health concern characterized by high mortality rates, further complicated by diagnostic challenges and the absence of reliable prognostic biomarkers. Objective: To investigate the clinical value of specific immunological parameters along with liver and kidney function tests in individuals with sepsis and their relationship to disease severity. Materials and Methods: In this research, we included 300 participants (100 healthy individuals as the control group and 200 patients in the sepsis group, including 100 with non-severe sepsis and 100 with severe sepsis). Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), C-X-C motif chemokine ligand 9 (CXCL9), C-C motif chemokine ligand 12 (CCL12), soluble urokinase plasminogen activator receptor (suPARIII), and monocyte chemoattractant protein-1 (MCP-1), creatinine (S-Cr), High-sensitive C-reactive protein (hs-CRP), platelet counts (PLT), and the PaO2/FiO2 ratio were measured for each participant. Results: Our results showed significantly increased (P-value < 0.05) levels of IL-6 and TNF-α in patients with non-severe sepsis and severe sepsis compared to the control group. The levels of CXCL9, CCL12, suPARIII, and MCP-1 were also significantly elevated in both non-severe sepsis and severe sepsis patients compared with the control group. Significantly higher levels of TSB, hs-CRP, and S-Cr were observed in the severe sepsis group compared to the control group. Conversely, platelet counts were markedly reduced in both non-severe and severe sepsis patients relative to controls. Conclusion: The study identified several critical immunological and biochemical markers that demonstrated a significant positive correlation with sepsis severity. Elevated levels of these immune response markers were consistently associated with more severe clinical presentations, underscoring their potential utility as early diagnostic and prognostic indicators in sepsis management.

Al- Anbar Medical JournalVol. 21(4)
Openalex Percentile: Top 15%
Sepsis Diagnosis and Treatment
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.